|
1
|
Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein.
|
Virology
|
1999
|
2.33
|
|
2
|
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor.
|
J Virol
|
1997
|
1.84
|
|
3
|
Differential subcellular localization of hepatitis C virus core gene products.
|
Virology
|
1995
|
1.73
|
|
4
|
Homotypic interaction and multimerization of hepatitis C virus core protein.
|
Virology
|
1996
|
1.51
|
|
5
|
Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes.
|
Biochemistry
|
1983
|
1.49
|
|
6
|
A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus.
|
Proc Natl Acad Sci U S A
|
1995
|
1.34
|
|
7
|
Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K.
|
J Biol Chem
|
1998
|
1.32
|
|
8
|
Purple membrane vesicles: morphology and proton translocation.
|
J Membr Biol
|
1977
|
1.29
|
|
9
|
Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema.
|
Eur J Pharmacol
|
1986
|
1.24
|
|
10
|
Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
|
Proc Natl Acad Sci U S A
|
1985
|
1.24
|
|
11
|
trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
|
J Biol Chem
|
1985
|
1.14
|
|
12
|
Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
|
Lab Invest
|
1985
|
1.14
|
|
13
|
Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene.
|
J Virol
|
1998
|
1.12
|
|
14
|
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist.
|
Biochem Biophys Res Commun
|
1988
|
1.07
|
|
15
|
Transient photovoltages in purple membrane multilayers. Charge displacement in bacteriorhodopsin and its photointermediates.
|
Biochim Biophys Acta
|
1978
|
1.06
|
|
16
|
Specific binding sites for platelet activating factor in human lung tissues.
|
Biochem Biophys Res Commun
|
1985
|
1.01
|
|
17
|
Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine.
|
Br J Radiol
|
2010
|
1.01
|
|
18
|
Proton transport by bacteriorhodopsin in planar membranes assembled from air-water interface films.
|
J Gen Physiol
|
1980
|
0.95
|
|
19
|
Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta-dependent pathway.
|
Biochem Biophys Res Commun
|
2001
|
0.94
|
|
20
|
Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes.
|
J Biol Chem
|
1986
|
0.94
|
|
21
|
Proton transport by bacteriorhodopsin through an interface film.
|
J Membr Biol
|
1977
|
0.92
|
|
22
|
Characterization of mRNA for hepatitis delta antigen: exclusion of the full-length antigenomic RNA as an mRNA.
|
Virology
|
1998
|
0.91
|
|
23
|
Species difference in the specific receptors of platelet activating factor.
|
Biochem Pharmacol
|
1986
|
0.91
|
|
24
|
Rac GTPase activity is essential for EGF-induced mitogenesis.
|
Mol Cells
|
1998
|
0.88
|
|
25
|
Prolongation of parturition in the pregnant rat following treatment with a platelet activating factor receptor antagonist.
|
Biol Reprod
|
1991
|
0.86
|
|
26
|
Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2.
|
Virus Res
|
2001
|
0.85
|
|
27
|
Structural and spectroscopic characteristics of bacteriorhodopsin in air-water interface films.
|
J Membr Biol
|
1977
|
0.84
|
|
28
|
Predictors of functional outcome after emergency carotid artery stenting and intra-arterial thrombolysis for treatment of acute stroke associated with obstruction of the proximal internal carotid artery and tandem downstream occlusion.
|
AJNR Am J Neuroradiol
|
2012
|
0.84
|
|
29
|
Membrane effects of antiinflammatory agents. 2. Interaction of nonsteroidal antiinflammatory drugs with liposome and purple membranes.
|
J Med Chem
|
1981
|
0.84
|
|
30
|
SUMOylation of nonstructural 5A protein regulates hepatitis C virus replication.
|
J Viral Hepat
|
2014
|
0.83
|
|
31
|
Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma.
|
Clin Radiol
|
2010
|
0.83
|
|
32
|
Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.
|
J Biol Chem
|
1986
|
0.82
|
|
33
|
Recent development of platelet-activating factor antagonists.
|
Adv Prostaglandin Thromboxane Leukot Res
|
1989
|
0.79
|
|
34
|
Characterization and translational regulation of the arginine decarboxylase gene in carnation (Dianthus caryophyllus L.).
|
Plant J
|
2000
|
0.78
|
|
35
|
Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication.
|
J Viral Hepat
|
2008
|
0.78
|
|
36
|
Nonstructural 5A protein of hepatitis C virus regulates heat shock protein 72 for its own propagation.
|
J Viral Hepat
|
2011
|
0.78
|
|
37
|
[Neolignans from Piper polysyphorum C.DC].
|
Yao Xue Xue Bao
|
1991
|
0.77
|
|
38
|
Conformation and activity of tetrahydrofuran lignans and analogues as specific platelet activating factor antagonists.
|
J Med Chem
|
1986
|
0.77
|
|
39
|
Functional domains of hepatitis delta antigen.
|
Prog Clin Biol Res
|
1993
|
0.77
|
|
40
|
Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor.
|
Pharmacol Res
|
2001
|
0.76
|
|
41
|
Endovascular management in patients with acute basilar artery obstruction: low-dose intra-arterial urokinase and mechanical clot disruption.
|
Interv Neuroradiol
|
2011
|
0.75
|
|
42
|
Balloon-expandable stent placement in patients with immediate reocclusion after initial successful thrombolysis of acute middle cerebral arterial obstruction.
|
Interv Neuroradiol
|
2012
|
0.75
|
|
43
|
(+/-)-trans-2-[3-methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N- hydroxyureidyl)methylphenyl]-5-(3,4, 5-trimethoxyphenyl)tetrahydrofuran (CMI-392), a potent dual 5-lipoxygenase inhibitor and platelet-activating factor receptor antagonist.
|
J Med Chem
|
1998
|
0.75
|
|
44
|
Light-dependent proton transport by bacteriorhodopsin incorporated in an interface film.
|
Prog Clin Biol Res
|
1977
|
0.75
|
|
45
|
Effects of nonsteroid antiinflammatory drugs on the specific binding of platelet activating factor to membrane preparations of rabbit platelets.
|
Thromb Res
|
1984
|
0.75
|
|
46
|
Structure-activity relationships of kadsurenone analogues.
|
J Med Chem
|
1987
|
0.75
|
|
47
|
[The investigation of lignans from Sargentodoxa cuneata (Oliv) Rehd et Wils].
|
Yao Xue Xue Bao
|
1986
|
0.75
|
|
48
|
The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
|
Int J Tissue React
|
1985
|
0.75
|
|
49
|
[Neolignans from Piper hancei Maxim].
|
Yao Xue Xue Bao
|
1986
|
0.75
|